Xylem Inc. $XYL Shares Bought by Pinnacle Associates Ltd.

Key Points

• Pinnacle Associates increased its Xylem stake by 3.6% in the third quarter, owning 274,578 shares valued at approximately $27.8 million. Institutional investors and hedge funds collectively hold 87.96% of Xylem’s outstanding stock.
• Xylem reported quarterly earnings of $1.46 per share, beating analyst expectations of $1.34, while revenue rose 1.5% year over year to $2.34 billion. The company provided fiscal 2026 EPS guidance of $5.55 to $5.70.
• The company maintains a quarterly dividend of $0.43 per share, equivalent to an annualized $1.72 and a 1.6% yield. Analysts give Xylem a consensus “Moderate Buy” rating with an average price target of $140.85.

Pinnacle Associates Ltd. grew its position in Xylem Inc. (NYSE:XYL - Free Report) by 3.6% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 274,578 shares of the industrial products company's stock after acquiring an additional 9,650 shares during the period. Pinnacle Associates Ltd. owned 0.12% of Xylem worth $27,807,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also modified their holdings of XYL. XXEC Inc. acquired a new stake in Xylem during the 2nd quarter valued at $850,841,000. BlackRock Inc. acquired a new position in Xylem in the second quarter worth $2,959,730,000. Bank of New York Mellon Corp acquired a new position in Xylem in the second quarter worth $552,313,000. Hsbc Holdings PLC bought a new stake in shares of Xylem during the second quarter worth $319,785,000. Finally, Deutsche Bank AG bought a new stake in shares of Xylem during the second quarter worth $223,165,000. 87.96% of the stock is owned by institutional investors and hedge funds.

Xylem Trading Up 1.4%

Shares of XYL opened at $104.96 on Wednesday. The stock's fifty day simple moving average is $107.69 and its 200-day simple moving average is $113.65. The firm has a market capitalization of $24.51 billion, a PE ratio of 24.99, a price-to-earnings-growth ratio of 1.67 and a beta of 1.00. Xylem Inc. has a 12-month low of $98.58 and a 12-month high of $154.27. The company has a quick ratio of 1.24, a current ratio of 1.61 and a debt-to-equity ratio of 0.23.

Xylem (NYSE:XYL - Get Free Report) last announced its quarterly earnings data on Tuesday, July 28th. The industrial products company reported $1.46 earnings per share for the quarter, beating the consensus estimate of $1.34 by $0.12. Xylem had a net margin of 11.15% and a return on equity of 11.77%. The business had revenue of $2.34 billion for the quarter, compared to analyst estimates of $2.34 billion. During the same period in the prior year, the business posted $1.26 earnings per share. Xylem's revenue was up 1.5% compared to the same quarter last year. Xylem has set its FY 2026 guidance at 5.550-5.700 EPS. As a group, research analysts predict that Xylem Inc. will post 5.65 earnings per share for the current year.

Xylem Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, September 24th. Stockholders of record on Thursday, August 27th were paid a $0.43 dividend. The ex-dividend date of this dividend was Thursday, August 27th. This represents a $1.72 dividend on an annualized basis and a dividend yield of 1.6%. Xylem's dividend payout ratio is 40.95%.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on XYL. Barclays cut their price target on Xylem from $159.00 to $139.00 and set an "overweight" rating for the company in a report on Tuesday, October 13th. Royal Bank Of Canada decreased their price objective on shares of Xylem from $164.00 to $135.00 and set an "outperform" rating on the stock in a report on Wednesday, October 14th. CLSA upgraded shares of Xylem to a "hold" rating in a research report on Thursday, June 25th. Jefferies Financial Group boosted their target price on shares of Xylem from $145.00 to $150.00 and gave the stock a "buy" rating in a research note on Monday, August 24th. Finally, Oppenheimer reaffirmed an "outperform" rating and issued a $150.00 target price (down from $158.00) on shares of Xylem in a research note on Wednesday, October 14th. Eight research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $140.85.

Xylem Company Profile

Xylem Inc NYSE: XYL is a global water technology company that develops products and services for the transportation, treatment, testing and efficient use of water and wastewater. Its offerings support municipal water and wastewater utilities, industrial customers, commercial facilities and residential applications.

The company's products and solutions include water and wastewater pumps, treatment systems, dewatering equipment, smart meters, monitoring and control technologies, leak detection tools, and data-driven analytics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.